<DOC>
	<DOCNO>NCT00608218</DOCNO>
	<brief_summary>The aim study evaluate efficacy ciclesonide patient persistent asthma 3 month , especially cold season . Ciclesonide inhale metered-dose inhaler . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Efficacy Ciclesonide During Cold Season Patients Older Than 12 Years With Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main inclusion criterion : History persistent bronchial asthma Main exclusion criterion : Hypersensitive compound Alvesco Other criterion define Summary Product Characteristics ( Fachinformation Chapter 4.3 )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>ciclesonide</keyword>
	<keyword>inhaled steroid</keyword>
	<keyword>Alvesco</keyword>
</DOC>